Abstract

During the organizational and functional development of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), more attention was paid to developing regions. In addition to the traditional annual meetings in Western Europe and North-America, the 1st Asia-Pacific Conference and the 1st Latin America Conference were organized in 2003 and 2007, respectively. In addition to Value in Health, its well-established journal, ISPOR introduced Value in Health Regional Issues (ViHRI), its new independent, official scientific journal in 2012. Its 1st volume, published in 2012, consisted of two issues covering the regions of Asia [1,2] and Latin America [3,4]. As of 2013, a special issue has been devoted to the regions of Central and Eastern Europe, Western Asia, and Africa (CEEWAA). Countries eligible from Central and Eastern Europe include Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Montenegro, Poland, Republic of Moldova, Romania, Russian Federation, Serbia, Slovakia, Slovenia, Ukraine, and The Former Yugoslav Republic of Macedonia. Countries eligible from Western Asia are Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Occupied Palestinian Territory, Oman, Qatar, Saudi Arabia, Syrian Arab Republic, Turkey, United Arab Emirates, and Yemen. All African countries are eligible.